ElectroWire Medical has received U.S. FDA 510(k) clearance for its LightningWire Transseptal Puncture System, a device indicated to create an atrial septal defect in the heart for the introduction of cardiovascular catheters.
The system combines an electrosurgical guidewire with a dedicated activation cable, allowing physicians to use preferred transseptal introducers and existing electrosurgical generators. ElectroWire said the system is designed to simplify transseptal puncture while supporting broad compatibility across different cardiovascular procedures.
This is relevant because transseptal access is a critical step in many left-sided heart interventions. Procedures such as catheter ablation for atrial fibrillation, left atrial appendage occlusion and transcatheter mitral valve repair or replacement often depend on safe and controlled access across the atrial septum.
LightningWire’s proprietary insulation design is intended to optimise electrosurgical performance and mechanical properties along the length of the wire. The company said robust distal insulation allows transseptal puncture at low power settings, while the 0.032-inch labelled diameter supports compatibility with various transseptal devices.
The guidewire is also described as stiffer than the market-leading 0.035-inch guidewire, which may help support efficient delivery of therapy devices into the left side of the heart. The activation cable connects to separately cleared electrosurgical generators and places control of radiofrequency energy in the operator’s hands within the sterile field.
The device is now moving into immediate commercialisation through a limited market release. This is an important step because adoption in interventional cardiology and electrophysiology depends heavily on physician experience, procedural reliability and compatibility with existing lab workflows.
The system’s value proposition lies in improving flexibility during transseptal procedures. If physicians can cross the septum using their preferred catheter systems while maintaining controlled electrosurgical access, the device may reduce procedural friction across multiple left-heart interventions.
